.While the biotech financial investment performance in Europe has actually slowed rather following a...
.After rearing $213 thousand in 2023-- among the year's largest private biotech shots-- Volume Biosc...
.Invite to this week's Chutes & Ladders, our summary of notable management hirings, shootings and...
.Venture capital backing right into biopharma rose to $9.2 billion all over 215 handle the 2nd quart...
.Bicara Therapeutics and also Zenas Biopharma have delivered new catalyst to the IPO market along wi...
.Genentech will certainly close its cancer cells immunology research department, as well as unit min...
.Kezar Lifestyle Sciences is actually falling its own unpromising phase 1 sound cyst drug as the bio...
.In spite of izokibep preserving its own newfound winning touch in the clinic, Acelyrin is no longer...
.Rivus Pharmaceuticals has plumped up the potential customers of its own fat-busting, muscle-sparing...
.Ovid Therapy already revealed last month that it was trimming its head count as the firm gets throu...